Omega-3 Shows Benefits for Fat Loss in Diabetics
By staff reporter
13/12/2007 - Supplementation with omega-3 fatty acids could reduce fat mass in diabetics, as well as improving blood lipid levels associated with the formation of arterial plaque, suggests a new study from France.
Twenty-seven women with type-2 diabetes took part in the study, published in this month's American Journal of Clinical Nutrition, which also reported no changes to overall energy intake after two months of omega-3 supplementation.
Omega-3 fatty acids have been linked to a wide-range of health benefits, including reduced risk of cardiovascular disease (CVD) and certain cancers, good development of a baby during pregnancy, joint health, and improved behaviour and mood.
The researchers, led by Morvarid Kabir from France's INSERM, randomly assigned the volunteers to receive either daily supplements of fish oil (three grams, providing 1.8 grams of omega-3) or placebo (paraffin oil) for two months. The subjects did not show signs of high triglyceride levels.
At the end of the study, Kabir and co-workers report significant reductions in total fat mass and the diameter of fat cells beneath the surface of the skin (subcutaneous adipocytes) in the omega-3, but not the placebo, group.
Moreover, risk factors for plaque formation in the arteries (atherogenic markers), such as triacylglycerol levels and the ration of triacylglycerol to HDL ('good') cholesterol, were significantly lower as a result of omega-3 supplementation, indicating considerable cardiovascular benefits for the women.
"A subset of inflammation-related genes was reduced in subcutaneous adipose tissue after the fish oil, but not the placebo," added the researchers.
No significant changes occurred in insulin sensitivity measures, they noted.
"A moderate dose of omega-3 PUFAs for two months reduced adiposity and atherogenic markers without deterioration of insulin sensitivity in subjects with type-2 diabetes," concluded the researchers.
"Some adipose tissue inflammation-related genes were also reduced. These beneficial effects could be linked to morphologic and inflammatory changes in adipose tissue."
Only recently, researchers from the University of Colorado at Denver reported that increased intake of omega-3 fatty acids from marine sources may protect children at high risk of type-1 diabetes from developing the disease (JAMA, Vol. 298, pp. 1420-1428).
An estimated 19 million people are affected by type-2 diabetes in the EU 25, equal to four per cent of the total population. This figure is projected to increase to 26 million by 2030.
In the US, there are over 20 million people with diabetes, equal to seven per cent of the population. The total costs are thought to be as much as $132 billion, with $92 billion being direct costs from medication, according to 2002 American Diabetes Association figures.
Source: American Journal of Clinical Nutrition
December 2007, Volume 86, 1670-1679
"Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study"
Authors: Morvarid Kabir, G. Skurnik, N. Naour, V. Pechtner, E. Meugnier, S. Rome, A. Quignard-Boulange, H. Vidal, G. Slama, K. Clement, M. Guerre-Millo and S.W. Rizkalla
For more information on Wellness check out the Health and Wellness section of the Library!
Omega-3's and omega-6's belong to a family of fats known as essential fatty acids. The right balance of these two types of fatty acids is important for the healthy functioning of many parts of the body, including brain development. Unfortunately, because the human body cannot manufacture these essential fatty acids, they must be provided through diet. These omega-3 and omega-6 fatty acids are found in fish, and seafood, some nuts and seeds and green leafy vegetables.
In a well-balanced diet, both omega-3's and omega-6's should be present. In modern diets, however, saturated fats and vegetable oils – all loaded with omega-6's – have become predominant. At the same time, the intake of omega-3 fatty acids from fish have declined while modern farming and commercial food production have further stripped foods of omega-3 content in an effort to prolong shelf life. The ideal omega-6 to omega-3 relationship is quoted at 4 to 1, but in persons who do not eat fish twice a week, experts believe that ratio is closer to 20 to 1, and is responsible for many of the health problems that plague us.
Given the heavy metals and other toxins found in fish, people are undertandably concerned about consuming significant amounts of seafood. And yet, by not consuming fish, we all miss the opportunity to obtain important omega-3 fats in the diet. Supplementation with a high-quality omega-3 product may be the answer.
WINOmeg3complex™ is a pharmaceutical grade omega-3 ethyl ester concentrate which is obtained from purified fish oil. The basic material is crude deep-sea fish oil.
WINOmeg3complex ™ contains 88% omega-3 ethyl esters with a 60% concentration of EPA for maximum anti-inflammatory benefit, making it approximately three times more potent than most omega-3 supplements currently available. This high concentration and optimal EPA to DHA blend is enhanced with natural lemon oil in the soft gel capsule for great lemon taste. One WINOmeg3complex™ soft gel capsule supplies 540mg of EPA and 160mg of DHA. The ratio of EPA to DHA is 3.3 to 1; a balance many experts believe is optimal for good health.
** This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
For more information - visit our Wellness section!